Rheumatologists must speak for themselves and their patients, because no one else will speak for us. Advocacy is necessary to educate elected officials and preserve our ability to provide the best care to our patients. One way to reach these officials is through the local media. Here are some tips on how to reach out to reporters, write op-eds and letters, and become a knowledgeable resource for your community…
Gene Expression Markers in T Cells Help Identify SLE Patient Subtypes
Researchers used T cell transcriptome analysis in a small-scale study, identifying gene expression of specific patient subtypes and finding that expression alteration of T cells may correlate with severity of SLE rather than its presentation…
More Than Half of U.S. Doctors Experience Burnout
(Reuters Health)—Burnout among U.S. doctors is becoming more common and now affects more than half of practicing physicians, according to a new study.¹ About 54% of U.S. doctors experienced at least one symptom of burnout in 2014, compared to about 46% in 2011, researchers report in Mayo Clinic Proceedings. Overall, the researchers found that doctors are…
U.S. House Speaker Ryan Says Obamacare Replacement Plan Coming Next Year
WASHINGTON (Reuters)—U.S. House Speaker Paul Ryan said on Thursday that Republicans next year will unveil a plan to replace President Barack Obama’s national healthcare program, widely known as Obamacare, in its entirety as part of a “pro-growth” Republican alternative to Democratic policies. “Next year, we are going to unveil a plan to replace every word…
NPs & PAs May Improve Care in Rheumatology Practices
A recent study examined the outcomes of care for RA patients provided by nurse practitioners or physician assistants working in tandem with rheumatologists, compared with that provided exclusively by rheumatologists. Over the two-year course of the study, results indicated that not only was care not compromised, but RA disease activity control may actually have been slightly better in these practices…
Annual Meeting Advocacy Recap
Advocacy was front and center at the 2015 ACR/ARHP Annual Meeting, and in case you missed something, Will Harvey, MD, provides a summary here…
Etanercept Biosimilars Promising in Clinical Studies
In multiple clinical studies, investigational biosimilars for etanercept were shown to be safe and effective for treating rheumatoid arthritis and moderate to severe plaque psoriasis…
Doctors in England Suspend Mass Walkout Until January after Talks
LONDON (Reuters)—Doctors in Britain’s state-funded health service announced on the eve of a planned mass walkout they would suspend it until January after “conciliatory talks” with the government over new pay and conditions. The strike had been due to start on Tuesday, involving doctors in training, or junior doctors, who represent just over half of…
Mycophenolate Sodium Effective for Chronic Noninfectious Pediatric Uveitis
NEW YORK (Reuters Health)—Mycophenolate sodium (MPS) is effective for treating children with chronic noninfectious uveitis, researchers from Germany report. “Mycophenolate sodium could be used as a preferred steroid-sparing agent in children with chronic noninfectious intermediate uveitis,” Dr. Deshka Doycheva, from the University of Tuebingen, Germany, told Reuters Health by email. MPS is an enteric-coated formulation…
One-Year Data Shows Apremilast Effective in Severe Scalp, Nail Psoriasis
NEW YORK (Reuters Health)—Apremilast is effective in patients with difficult to treat psoriasis of the scalp and nails, according to long-term results of two phase 3 trials. Investigators had previously reported 16-week data from the Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) 1 and 2 trials. The new report includes…
- « Previous Page
- 1
- …
- 543
- 544
- 545
- 546
- 547
- …
- 820
- Next Page »